Speech Learning and Speech Production in Parkinson's Disease
Recruiting · NCT07403539 · Interventional (participants receive a specific treatment) · Lead sponsor: State University of New York at Buffalo
View the official record on ClinicalTrials.gov →Interventions studied
Intensity discriminationIntensity learningRate discriminationRate learning
What this trial is about
Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. By linking these two abilities in individuals with Parkinson's disease using a precision medicine approach, this project seeks to build a basis for new therapies that help people with Parkinson's disease both understand better and speak more clearly.
Who can take part
Age range
45 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of Parkinson's disease
- Native speaker of North American English
- Use a drug that includes levodopa
- Resident of the United States
Exclusion criteria
- Any history of language, hearing or speech disorder outside of Parkinson's disease
- Other gross neurological impairment such as Alzheimer's disease or stroke
- Significant hearing loss and/or use of a hearing aid or cochlear implant
Where it is running
1 location listed across 1 US state.
- State University of New York at Buffalo - Buffalo, New York, United States